Neuralink targets high-volume implant production and automated surgical procedures
Evidence notes
- Neuralink targeted high-volume production of its brain-computer interface devices beginning in 2026.
- The same report described a planned transition toward fully automated surgical implantation procedures.
- The update links Neuralink's implant scale-up to automation around a robot-assisted medical workflow.
Company context
Neuralink develops implantable brain-computer interfaces and the R1 surgical robot used to place ultra-fine electrode threads.